The Jacobs Institute appears in FDA device records as the applicant on a single 510(k) submission, K262132, for a product named 3D Anatomical Model. The filing carries product code LLZ, device class 2, regulation number 892.2050, and the openFDA device name System, Image Processing, Radiological, with radiology as the advisory committee. The record shows a Traditional clearance type, a summary statement, and no third-party review. The organization's own published pages describe anatomical model development, design and development, pre-clinical device testing, and regulatory and quality services, which places the filing alongside documented services rather than a standalone product line. [1][2][3][6]
The K262132 submission and its scope
FDA records show K262132 received on June 24, 2026 and decided on November 5, 2026 with decision code SESE, described as Substantially Equivalent. The applicant is listed as The Jacobs Institute at 875 Ellicott St., 5th Floor, Buffalo, NY 14203, and the device is named 3D Anatomical Model. The submission is a Traditional 510(k) with a summary statement and no expedited review flag. [1]
The classification data attached to the record places the device in class 2 under regulation 892.2050, product code LLZ, with the openFDA device name System, Image Processing, Radiological and radiology as both advisory committee and review advisory committee. The record does not describe the model's materials, anatomical targets, or intended clinical use beyond that classification. [1]
Published model development and design work
The Jacobs Institute's anatomical model development page describes services intended to accelerate device development through testing, and lists contact details at 875 Ellicott St., 5th Floor, Buffalo, NY 14203. The page sits within a product development menu that also includes ideation and proof of concept, design and development, facilities and equipment, and pre-clinical device testing. [2]
Its design and development page describes design optimization work, including generating design specifications through anatomical charting and preparing a Design History File to support pre-clinical testing strategy. The same page states that the organization is certified to ISO 13485:2016 for the research, design, development, and manufacture of vascular and related medical devices and anatomical models, and for engineering, validation, testing, simulation, and related technical services. [3]
Testing, facilities and regulatory services
The pre-clinical device testing page frames testing around in-vitro, in vivo, and ex vivo models performed in the same place with the same team, and repeats the ISO 13485:2016 certification language covering vascular and related medical devices and anatomical models. The facilities and equipment page lists prototyping equipment including a laser welder, laser cutter, Yamato convection oven, and TPU among the tools described. [4][6]
The Office of Regulatory Services and Office of Quality Services page describes help for entrepreneurs with vascular or neuro device ideas, including determining FDA oversight for emerging neuro technologies, identifying regulatory pathways, and practices for contacting FDA. Separate brochures for the regulatory and quality offices are offered for download. [5]
What the record does and does not establish
The linked collection contains one 510(k) record, and the record sample contains that same single entry, decided SESE. That count reflects the filings retrieved as of November 20, 2026 and is not a measure of total company output, sales, or safety performance. No recall records appear in the retrieved sample. [1]
The FDA record identifies The Jacobs Institute as the applicant and gives a Buffalo, New York filing address; it does not establish a headquarters, ownership structure, parent company, or commercial availability of the model. The published pages describe services and certification scope but do not report clinical performance, customer names, or pricing. [1][2][3]
